CIK 0000836564 · Non-accelerated filer<br>Smaller reporting company
Mosaic ImmunoEngineering Inc.
Sign in to watch- Ticker
- CPMV
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 841070278
- Phone
- 657-208-0890
- Business address
- 9114 ADAMS AVE., #202, HUNTINGTON BEACH, CA, 92646
- Former names
- PATRIOT SCIENTIFIC CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-02-18 | KING STEVEN W President and CEO | Other acquisition · Convertible Note | +0 | $20,000.00 | $0 | |
| 2022-02-18 | FELCYN GLORIA Director | Other acquisition · Convertible Note | +0 | $25,000.00 | $0 | |
| 2022-02-18 | GARNICK ROBERT L Director | Other acquisition · Convertible Note | +0 | $50,000.00 | $0 | |
| 2022-02-18 | BAFFI ROBERT Director | Other acquisition · Convertible Note | +0 | $50,000.00 | $0 | |
| 2022-02-18 | Steinmetz Nicole Franziska Director | Other acquisition · Convertible Note | +0 | $10,000.00 | $0 | |
| 2021-05-07 | GARNICK ROBERT L Director | Other acquisition · Convertible Note | +0 | $100,000.00 | $0 | |
| 2021-05-07 | FELCYN GLORIA Director | Other acquisition · Convertible Note | +0 | $25,000.00 | $0 | |
| 2021-04-29 | Steinmetz Nicole Franziska Director | Grant or award · Restricted Stock Units | +5,357 | $2.80 | $15K | 5,357 |
| 2021-01-29 | Steinmetz Nicole Franziska Acting CSO | Conversion | +1,641,252 | 1,641,252 | ||
| 2021-01-29 | Steinmetz Nicole Franziska Acting CSO | Conversion | +570,870 | 570,870 | ||
| 2021-01-29 | Steinmetz Nicole Franziska Acting CSO | Conversion · Series A Convertible Voting Preferred Stock | −161,000 | 0 | ||
| 2021-01-29 | Steinmetz Nicole Franziska Acting CSO | Conversion · Series A Convertible Voting Preferred Stock | −56,000 | 0 | ||
| 2021-01-29 | LYTLE PAUL J EVP, Chief Financial Officer | Conversion | +1,641,252 | 1,641,252 | ||
| 2021-01-29 | LYTLE PAUL J EVP, Chief Financial Officer | Conversion · Series A Convertible Voting Preferred Stock | −161,000 | 0 | ||
| 2021-01-29 | KING STEVEN W President and CEO | Conversion | +1,641,252 | 1,641,252 | ||
| 2021-01-29 | KING STEVEN W President and CEO | Conversion · Series A Convertible Voting Preferred Stock | −161,000 | 0 | ||
| 2021-01-29 | GARNICK ROBERT L Director | Conversion | +356,794 | 356,794 | ||
| 2021-01-29 | GARNICK ROBERT L Director | Conversion · Series A Convertible Voting Preferred Stock | −35,000 | 0 | ||
| 2020-12-16 | FELCYN GLORIA Director | Grant or award · Restricted Stock Units | +26,087 | $3.30 | $86K | 26,087 |
| 2020-12-16 | LYTLE PAUL J EVP, Chief Financial Officer | Grant or award · Restricted Stock Units | +42,392 | $3.30 | $140K | 42,392 |
Page 1 of 12 · 235 trades